318
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy

, , &
Pages 228-233 | Received 14 Apr 2016, Accepted 11 Aug 2016, Published online: 07 Sep 2016

Reference

  • Abdel-Salam FS, Mahmoud AA, Ammar HO, et al. (2016). Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate. J Liposome Res. [Epub ahead of print]. doi: 10.3109/08982104.2016.1149866
  • Abul Kalam M, Sultana Y, Ali A, et al. (2013). Part II: enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. J Biomed Mater Res A 101:1828–36
  • Ali J, Fazil M, Qumbar M, et al. (2016). Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv 23:710–26
  • Amekyeh H, Billa N, Yuen KH, et al. (2015). A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats. AAPS PharmSciTech 16:871–7
  • Ansari Z, Miller D, Galor A. (2013). Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep 7:209–18
  • Chhonker YS, Prasad YD, Chandasana H, et al. (2015). Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol 72:1451–8
  • de Campos AM, Diebold Y, Carvalho EL, et al. (2004). Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 21:803–10
  • Di Colo G, Zambito Y, Burgalassi S, et al. (2004). Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin. Int J Pharm 273:37–44
  • Diebold Y, Jarrín M, Sáez V, et al. (2007). Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28:1553–64
  • Fukui H, Koike T, Saheki A, et al. (2003). A novel delivery system for amphotericin B with lipid nano-sphere (LNS). Int J Pharm 265:37–45
  • Ibrahim F, Gershkovich P, Sivak O, et al. (2013). Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats. Drug Dev Ind Pharm 39:1277–83
  • Kaur L, Jain SK, Manhas RK, et al. (2015). Nanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessment. J Liposome Res 25:294–307
  • la Fuente M, Raviña M, Paolicelli P, et al. (2010). Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 62:100–17
  • Li X, Nie SF, Kong J, et al. (2008). A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 363:177–82
  • Ludwig A. (2005). The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 57:1595–639
  • Luo Q, Zhao J, Zhang X, et al. (2011). Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 403:185–91
  • Puglia C, Offerta A, Carbone C, et al. (2015). Lipid nanocarriers (LNC) and their applications in ocular drug delivery. Curr Med Chem 22:1589–602
  • Schoenwald RD, Huang HS. (1983). Corneal penetration behavior of beta-blocking agents I: physiochemical factors. J Pharm Sci 72:1266–72
  • Shi W, Wang T, Xie L, et al. (2010). Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation. Ophthalmology 117:890–6
  • Short BG. (2008). Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol Pathol 36:49–62
  • Souto EB, Doktorovova S, Gonzalez-Mira E, et al. (2010). Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr Eye Res 35:537–52
  • Suresh PK, Sah AK. (2014). Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions. Expert Opin Drug Deliv 11:1747–68
  • Tan TR, Hoi KM, Zhang P, et al. (2016). Characterization of a polyethylene glycol-amphotericin B conjugate loaded with free AMB for improved antifungal efficacy. PLoS One 11:e0152112
  • Tian B, Luo Q, Song S, et al. (2012). Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. J Pharm Sci 101:1040–9
  • Tuncay Tanrıverdi S, Hilmioğlu Polat S, Yeşim Metin D, et al. (2016). Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation. J Liposome Res 26:163–73
  • Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, et al. (2014). Preparation and in vitro–in vivo evaluation of ofloxacin loaded ophthalmic nanostructured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur J Pharm Sci 63:204–15
  • Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, et al. (2015). Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis. Expert Opin Drug Deliv 12:1791–807
  • Verma P, Gupta RN, Jha AK, et al. (2013). Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide. Drug Deliv 20:269–76
  • Wagner ME, Rizvi SS. (2015). Novel method of niosome generation using supercritical carbon dioxide part I: process mechanics. J Liposome Res 25:334–46
  • Wang F, Chen L, Jiang S, et al. (2014). Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box–Behnken design. J Liposome Res 24:171–81
  • Wang J, Zhu R, Sun X, et al. (2014). Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway. Int J Nanomed 9:3987–98
  • Wang L, Sun S, Jing Y, et al. (2009). Spectrum of fungal keratitis in central China. Clin Exp Ophthalmol 37:763–71
  • Wang L, Luo Q, Lin T, et al. (2015). PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Dev Ind Pharm 41:1204–12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.